Fluorescent imaging agent detects cervical cancer in real time
The novel radiopharmaceutical may one day eliminate the need for needle biopsies, according to Memorial Sloan Kettering Cancer Center researchers.
View ArticleFDA awards clearance to first portable PET scanner
The BBX-PET machine can be wheeled into a physician's office, hospital room, or other healthcare settings to deliver point-of-care service.
View ArticleGE Healthcare, NorthStar sign exclusive radioisotope agreement
The deal includes manufacturing and distribution rights for Iodine-123 capsules, commonly used during thyroid imaging exams.
View ArticleHybrid PET/MRI spares 20% of brain tumor patients from unnecessary follow-up...
18F-FET PET/MR also changed providers' clinical management plans in more than 30% of cases, experts reported recently.
View ArticlePractices not aligned on renal scintigraphy protocols—it may be hurting...
Thirty-five different techniques for administering diuretics are used across 105 sites, authors reported in JACR.
View ArticleACR warns against using ‘arbitrary’ radiation dose metrics to guide medical...
Relying on pre-established dose guidance can keep patients from undergoing clinically necessary exams, top radiation safety organizations cautioned in a new joint statement.
View ArticleUS regulators considering changes to long-standing extravasation reporting...
A U.S. Nuclear Regulatory Commission subcommittee recommends mandatory reporting of certain skin damage caused by radiation, but the suggestion is far from finalized.
View ArticleTransformative prostate cancer therapy ‘should not be accepted’ without PET...
Two Stanford University experts made their case for using molecular imaging to select patients for 177-Lu-PSMA-617 in a new Journal of Nuclear Medicine editorial.
View ArticleNorthStar wins federally backed $37M agreement to advance Mo-99 capabilities
With this new award, the Beloit, Wisconsin, company has received upward of $100M in cooperative agreements from the U.S. Department of Energy.
View ArticleHybrid PET/MRI tops multiparametric MRI for detecting clinically significant...
Researchers tested Gallium 68-labeled PSMA-PET/MRI in patients who had yet to undergo a biopsy, a key difference from most prior analyses, they explained in Radiology.
View ArticleLawmakers request records from FDA on Alzheimer’s drug approval, citing...
Part of their list includes info regarding the agency's move to approve Aduhelm for broader treatment indications than studied during clinical testing, a gripe similar to complaints cited by SNMMI.
View ArticleHealth system teams up with radiopharmaceutical specialist to advance PSMA...
The memorandum of understanding agreement will focus on expanding patients' access to molecular imaging and establishing Kettering Health as a regional center of excellence.
View ArticleHybrid PET/CT early after treatment guides crucial decisions for many liver...
Follow-up imaging 4-8 weeks after transarterial radioembolization predicted six-month treatment response and overall survival.
View ArticleNew PET imaging agent alters prostate cancer plan for more than 40% of patients
Lantheus recently presented early results from the OSPREY trial during the American Urological Association's virtual meeting.
View ArticleNational cancer network adds PSMA-PET agents to new prostate imaging guidelines
National Comprehensive Cancer Network recommendations are widely recognized by providers and payers as the standard for clinical policy in oncology.
View Article‘Practice changing’: New research underscores clinical benefits of PSMA-PET...
California nuclear medicine experts said the technology will ultimately become part of routine staging for the disease, publishing their study findings in JAMA Oncology.
View ArticleAmyloid PET pinpoints ‘tipping point’ for developing Alzheimer’s dementia
Washington University in St. Louis experts say they can estimate how far dementia has progressed and how much time is left before cognitive impairment sets in.
View ArticleTop medical groups release new appropriate use criteria for PSMA-PET imaging
SNMMI is among the many organizations that collaborated on the updated guidance for imaging prostate cancer.
View Article‘A troublesome trend’: Top imaging groups slam insurer-directed test...
Advocates say payers' push for single first-line imaging tests for all patients isn't backed by evidence and may cause harm.
View ArticleFDA-approved PET agent helps solve 87% of diagnostic breast cancer dilemmas
In 93% of solved cases, experts based their decisions solely on 18F-FES PET scan results.
View Article
